BioTuesdays

Category - Markets

RXi Logo
Markets

HCW starts RXi Pharma at buy; PT $3

H.C. Wainwright launched coverage of RXi Pharmaceuticals (NASDAQ:RXII) with a “buy” rating and price target of $3. The stock closed at $1.97 on July 6. RXi is focused on improving the efficiency and anti-tumor activity...

July 9, 2018
Epizyme Logo
Markets

Leerink cuts Epizyme to market perform and PT to $16

Leerink downgraded Epizyme (NASDAQ:EPZM) to “market perform” from “outperform” and lowered its price target to $16 from $24 after making extensive changes to its revenue forecasts for Epizyme’s only drug, tazemetostat...

July 3, 2018
Celyad Logo
Markets

HCW starts Celyad at buy; PT $45

H.C. Wainwright initiated coverage of Celyad (NASDAQ:CYAD) with a “buy” rating and $45 price target, citing the outlook of the company’s pipeline that includes lead candidate, CYAD-01. The stock closed at $30.99...

July 2, 2018
Neuronetics Logo
Markets

Neuronetics prices IPO at $17 a share

Neuronetics (NASDAQ:STIM) priced its initial public offering of 5.5 million shares common shares at $17 each. The company also granted underwriters a 30-day option to purchase up to an additional 825,000 shares at the...

June 29, 2018
AquaBounty Logo
Markets

HCW starts AquaBounty at buy; PT $3.75

H.C. Wainwright launched coverage of AquaBounty Technologies (NASDAQ:AQB) with a “buy” rating and a “conservative” $3.75 price target. The stock closed at $2.99 on June 27. AquaBounty is focused on enhancing...

June 28, 2018
TransEnterix
Markets

BTIG cuts TransEnterix to neutral on rapid stock rise

BTIG downgraded TransEnterix (NASDAQ:TRXC) to “neutral” from “buy,” citing a tripling in the stock price, which has exceeded its price target of $3.50. The stock closed at $5.84 on June 27. “We continue to like the...

June 28, 2018
Imagin Medical Logo
Markets

Imagin Medical uplists to OTCQB

The common shares of Imagin Medical (CSE:IME; OTC:IMEXF) were approved for uplisting from the Pink Open Market to the OTCQB Venture Market, with the same symbol, IMEXF, effective at the open on June 28, 2018. “Uplisting...

June 28, 2018
Zosano Logo
Markets

BTIG starts Zosano Pharma at buy; PT $19

BTIG launched coverage of Zosano Pharma (NASDAQ:ZSAN) with a “buy” rating and 12-month price target of $19. The stock closed at $3.80 on June 27. Zosano is focused on the development of therapeutics using its ADAM...

June 28, 2018
Palatin Technologies Logo
Markets

Ladenburg starts Palatin Technologies at buy; PT $3

Ladenburg Thalmann initiated coverage of Palatin Technologies (NYSE MKT:PTN) with a “buy” rating and $3 price target. The stock closed at $1.05 on June 26. Palatin’s lead asset, bremelanotide (BMT), is a melanocortin...

June 27, 2018